MedTrace Logo

Comprehensive DNA Methylation Profiling in Crohn's Disease

NCT03272152 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2017-09-05

No results posted yet for this study

Summary

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed ileal mucosa of patients with Crohn's disease was performed. Genome-wide DNA methylation was determined using the Illumina HumanMethylation 850k BeadChip.

Conditions

  • Crohn Disease
  • Methylation
  • Illumina Human Methylation 850k BeadChip

Interventions

GENETIC

Genome-wide DNA methylation

Genome-wide DNA methylation was determined using the Infinium Human Methylation 850K BeadChip.

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03272152 on ClinicalTrials.gov